Qiyuan Pharmaceutical Honored as a "2022 Outstanding Enterprise for Fulfilling Social Responsibility"

In March 2023, Qiyuan Pharmaceutical was recognized as an "Outstanding Enterprise for Fulfilling Social Responsibility in 2022" and received a commendation from the Yinchuan Municipal Bureau of Industry and Information Technology.

To thoroughly implement the “Implementation Opinions on Improving Corporate Governance Systems and Enhancing Governance Capabilities”—issued during the 10th Plenary Session of the 12th Autonomous Region Party Committee—various departments, including the Autonomous Region Department of Industry and Information Technology, the Development and Reform Commission, the Department of Human Resources and Social Security, the Department of Ecology and Environment, the Department of Emergency Management, the Department of Market Regulation, the Federation of Trade Unions, and the Tax Bureau, jointly issued a directive on May 20, 2022, to launch the 2022 evaluation of social responsibility fulfillment among industrial enterprises.

Guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, this evaluation targeted the Autonomous Region's industrial enterprises "above designated size" (as of the end of 2021) and state-level "Specialized, Refined, and New" "Little Giant" enterprises (31 entities). Adhering to the “Ningxia Guidelines for Evaluating Social Responsibility Fulfillment in Industrial Enterprises”, the assessment was structured around four major dimensions—"Economic," "Environmental," "Social," and "Corporate Governance"—which were further broken down into 25 second-tier indicators and 75 third-tier indicators. These served as the specific criteria for both corporate self-assessment and the scoring evaluations conducted by relevant government departments. The evaluation process was carried out through a comprehensive approach combining corporate self-assessment, departmental evaluation, and third-party review. The data collection period for the evaluation spanned from January 1 to December 31, 2021, with economic indicator data specifically based on the 2021 financial audit report. The evaluation workflow encompassed various stages, including data collection, guidance on report drafting, analysis and verification, and the compilation of the “Blue Book on Corporate Social Responsibility Fulfillment”.

The application process for this initiative was characterized by a tight schedule and extensive content, necessitating the utmost accuracy in data and thoroughness in documentation. Administrative Director Xing Li attached great importance to this application project; the preliminary work was entirely organized by the Administrative Department, which—with the full cooperation of other relevant departments—successfully completed the submission, thereby demonstrating a highly professional and efficient work ethic.

Qiyuan Pharmaceutical has consistently integrated the fulfillment of social responsibility into its core corporate values. The company remains steadfast in its commitment to optimizing its industrial structure, strengthening energy conservation and emission reduction efforts, and prioritizing environmental protection, while actively engaging in initiatives aimed at fostering a harmonious corporate environment. During the period of epidemic prevention and control, our company actively heeded the government's call. While rigorously maintaining our own internal preventive measures, we organized production in a robust and orderly manner, successfully fulfilling our mission to ensure product supply. By fully discharging our social responsibilities, we made significant contributions to epidemic control and socio-economic development within the Autonomous Region and Yinchuan City. Furthermore, we demonstrated our corporate mission and sense of duty to the public, earning widespread recognition and acclaim from all sectors of society. It is precisely because of our scientific and standardized management, our commitment to integrity and ethical business practices, our unwavering focus on product quality, our diligent safeguarding of employee rights, our conscientious fulfillment of corporate social responsibilities, and our active engagement in public welfare initiatives—striving to give back to society and exemplifying a spirit of public service—that we stood out among the 326 enterprises evaluated in our city. Consequently, we received a commendation from the Municipal Bureau of Industry and Information Technology and were honored with the top ranking.

This award serves as a testament to the recognition bestowed upon Qiyuan Pharmaceutical by the government, society, and the general public; for Qiyuan Pharmaceutical, however, it marks a brand-new beginning. In the days ahead, guided by a profound sense of social responsibility and duty, Qiyuan Pharmaceutical will continue to push boundaries and raise the bar, striving to make new and even greater contributions to the advancement of public welfare initiatives and the construction of a harmonious society.